𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients

✍ Scribed by RG Gish; JY Lau; L Brooks; JW Fang; SL Steady; JC Imperial; R Garcia-Kennedy; CO Esquivel; EB Keeffe


Book ID
118686086
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
363 KB
Volume
23
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ganciclovir treatment of hepatitis B vir
✍ R G Gish; J Y Lau; L Brooks; J W S Fang; S L Steady; J C Imperial; R Garcia-Kenn πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 366 KB πŸ‘ 2 views

To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm

Chronic hepatitis E virus infection in l
✍ Elizabeth B. Haagsma; Arie P. van den Berg; Robert J. Porte; Cornelis A. Benne; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 318 KB πŸ‘ 1 views

Hepatitis E virus (HEV) infection is known to run a self-limiting course. Sporadic cases of acute hepatitis due to infection with HEV genotype 3, present in pig populations, are increasingly recognized. Zoonotic transmission seems infrequent. The entity of unexplained chronic hepatitis after liver t

Prevalence of hepatitis E virus infectio
✍ Elizabeth B. Haagsma; Hubert G. M. Niesters; Arie P. van den Berg; Annelies Riez πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 1 views

Hepatitis E virus (HEV) infection is known to run a self-limited course. Recently, chronic hepatitis E has been described in several immunosuppressed patients after solid organ transplantation. The prevalence of HEV infection after transplantation, however, is unknown. We studied HEV parameters [HEV